1.Does humeral fixation technique affect long-term outcomes of total shoulder arthroplasty?
Troy LI ; Kenneth H. LEVY ; Akiro H. DUEY ; Akshar V. PATEL ; Christopher A. WHITE ; Carl M. CIRINO ; Alexis WILLIAMS ; Kathryn WHITELAW ; Dave SHUKLA ; Bradford O. PARSONS ; Evan L. FLATOW ; Paul J. CAGLE
Clinics in Shoulder and Elbow 2023;26(3):245-251
Background:
For anatomic total arthroscopic repair, cementless humeral fixation has recently gained popularity. However, few studies have compared clinical, radiographic, and patient-reported outcomes between cemented and press-fit humeral fixation, and none have performed follow-up for longer than 5 years. In this study, we compared long-term postoperative outcomes in patients receiving a cemented versus press-fit humeral stem anatomic arthroscopic repair.
Methods:
This study retrospectively analyzed 169 shoulders that required primary anatomic total shoulder arthroplasty (aTSA). Shoulders were stratified by humeral stem fixation technique: cementation or press-fit. Data were collected pre- and postoperatively. Primary outcome measures included range of motion, patient reported outcomes, and radiographic measures.
Results:
One hundred thirty-eight cemented humeral stems and 31 press-fit stems were included. Significant improvements in range of motion were seen in all aTSA patients with no significant differences between final cemented and press-fit stems (forward elevation: P=0.12, external rotation: P=0.60, and internal rotation: P=0.77). Patient reported outcome metrics also exhibited sustained improvement through final follow-up. However, at final follow-up, the press-fit stem cohort had significantly better overall scores when compared to the cemented cohort (visual analog score: P=0.04, American Shoulder and Elbow Surgeon Score: P<0.01, Simple Shoulder Test score: P=0.03). Humeral radiolucency was noted in two cemented implants and one press-fit implant. No significant differences in implant survival were observed between the two cohorts (P=0.75).
Conclusions
In this series, we found that irrespective of humeral fixation technique, aTSA significantly improves shoulder function. However, within this cohort, press-fit stems provided significantly better outcomes than cemented stems in terms of patient reported outcome scores.Level of evidence: III.
2.Evaluating the effects of age on the long-term functional outcomes following anatomic total shoulder arthroplasty
Troy LI ; Akiro H. DUEY ; Christopher A. WHITE ; Amit PUJARI ; Akshar V. PATEL ; Bashar ZAIDAT ; Christine S. WILLIAMS ; Alexis WILLIAMS ; Carl M. CIRINO ; Dave SHUKLA ; Bradford O. PARSONS ; Evan L. FLATOW ; Paul J. CAGLE
Clinics in Shoulder and Elbow 2023;26(3):231-237
Methods:
Among the patients who underwent TSA, 119 shoulders were retrospectively analyzed. Preoperative and postoperative clinical outcome data were collected. Linear regression analysis (univariate and multivariate) was conducted to evaluate the associations of clinical outcomes with age. Kaplan-Meier curves and Cox regression analyses were performed to evaluate implant survival.
Results:
At final follow-up, patients of all ages undergoing aTSA experienced significant and sustained improvements in all primary outcome measures compared with preoperative values. Based on multivariate analysis, age at the time of surgery was a significant predictor of postoperative outcomes. Excellent implant survival was observed over the course of this study, and Cox regression survival analysis indicated age and sex to not be associated with an increased risk of implant failure.
Conclusions
When controlling for sex and follow-up duration, older age was associated with significantly better patient-reported outcome measures. Despite this difference, we noted no significant effects on range of motion or implant survival.Level of evidence: IV.
3.Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors.
Kuan HU ; Wenyu WU ; Lin XIE ; Hao GENG ; Yiding ZHANG ; Masayuki HANYU ; Lulu ZHANG ; Yinghuan LIU ; Kotaro NAGATSU ; Hisashi SUZUKI ; Jialin GUO ; Yundong WU ; Zigang LI ; Feng WANG ; Mingrong ZHANG
Acta Pharmaceutica Sinica B 2022;12(3):1363-1376
Peptides that are composed of dextrorotary (d)-amino acids have gained increasing attention as a potential therapeutic class. However, our understanding of the in vivo fate of d-peptides is limited. This highlights the need for whole-body, quantitative tracking of d-peptides to better understand how they interact with the living body. Here, we used mouse models to track the movement of a programmed death-ligand 1 (PD-L1)-targeting d-dodecapeptide antagonist (DPA) using positron emission tomography (PET). More specifically, we profiled the metabolic routes of [64Cu]DPA and investigated the tumor engagement of [64Cu/68Ga]DPA in mouse models. Our results revealed that intact [64Cu/68Ga]DPA was primarily eliminated by the kidneys and had a notable accumulation in tumors. Moreover, a single dose of [64Cu]DPA effectively delayed tumor growth and improved the survival of mice. Collectively, these results not only deepen our knowledge of the in vivo fate of d-peptides, but also underscore the utility of d-peptides as radiopharmaceuticals.